rozanolixizumab

Spain

Drugs containing this active substance

  • RYSTIGGO 140 MG/ML SOLUTION FOR INJECTION

    It is used in adults to treat generalized myasthenia gravis (gMG), an autoimmune disease that causes muscle weakness, extreme fatigue, and difficulty breathing or swallowing.

    Form: solution for injection

    Active substance Dosage
    rozanolixizumab 280 mg

    ATC: L04A L04AL L04AL02

    Manufacturer: Ucb Pharma